To require the Secretary of Health and Human Services to conduct a study on pharmacy benefit manager audit practices.
Latest Action
Referred to the Subcommittee on Health.
Official Summary
Official summary has not been imported yet.
GovScope Watchdog™
AI Government Intelligence™H.R. 10050 is a bill introduced in the 118th Congress that would require the Secretary of Health and Human Services to conduct a study on the audit practices of pharmacy benefit managers (PBMs). The bill aims to gather information on how PBMs conduct audits, which are reviews of pharmacies' billing and operations related to prescription drug benefits. The study would provide data to inform potential future policy decisions regarding PBM oversight and regulation. The bill was referred to the House Subcommittee on Health but did not advance further and ultimately expired.
This bill sought to initiate a government study on pharmacy benefit manager audit practices but did not progress beyond subcommittee referral and expired without enactment.
- The bill mandates a study by the Secretary of Health and Human Services focused on PBM audit practices.
- No specific regulatory or enforcement actions are included; the bill is limited to information gathering.
- The bill was referred to the House Subcommittee on Health on December 17, 2024, but did not advance and expired.
['Health and Human Services Department, which would conduct the study', 'Pharmacies and pharmacy benefit managers, as the study concerns their audit practices', 'Policymakers and stakeholders interested in prescription drug benefit management']
['The bill does not specify funding sources or timelines for the study, which may affect implementation feasibility.', 'Without further legislative action, the study alone may not lead to changes in PBM audit oversight.', 'The scope and methodology of the study are not detailed, which could impact the comprehensiveness and usefulness of findings.']
The bill was introduced in the House during the 118th Congress and referred to the Subcommittee on Health. It addresses ongoing policy discussions about the role and practices of pharmacy benefit managers in the healthcare system. However, the bill did not advance beyond subcommittee referral and expired, indicating limited legislative momentum during this session.
Hidden impact flags detected: 2
GovScope reviewed 2 policy-risk categories. Hover for a quick definition. Click detected flags for bill-specific details.
['The study could inform future legislation or regulatory actions concerning PBM audit practices.', 'Increased transparency from the study might influence pharmacy and PBM operational practices.', 'Data gathered may affect negotiations or disputes between pharmacies and PBMs.']
Transparency considerations include the absence of detailed study parameters and funding, which may impact the study's execution and utility. Oversight mechanisms for the study's completion and reporting are not specified. The bill's failure to advance limits its immediate impact but highlights ongoing interest in PBM practices.
GovScope Intelligence Roadmap
Future bill intelligence will connect sponsors, committee referrals, related votes, campaign finance, disclosures, and stock trades into one legislative intelligence view.